Discovery of TIGIT-Targeted Small Molecules as Cancer Therapies

Key Points

• This research aims to identify small molecules that target the immune checkpoint TIGIT, potentially offering new cancer therapies.
• Employed machine learning to identify potential binding sites on TIGIT.
• Conducted pharmacophore tests to evaluate binding requirements for inhibitors.
• Identified several small molecules that effectively bind to TIGIT.
• Demonstrated the potential of these inhibitors in modulating immune responses against cancer.